MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Interest Expense

Cost of servicing the company's debt during the period.

MindWalk Holdings Corp.NASDAQ: HYFT

Interest Expense · Q3 FY2026 · quarter ended Jan 2026

Interest expense remains negative

Q3 FY2026 interest expense was CA$0, compared with CA$3.11K a year earlier. Trailing-twelve-month interest expense was CA$1.94K. Over 3 fiscal years it compounded at -51.1% a year.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$486.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
CA$0— QoQ
Last fiscal yearApr 2025
CA$9.91K-47.8% YoY
LTMJan 2026
CA$1.94K-84.1% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-47.8%——
3-year CAGR-51.1%——
5-year CAGR——
10-year CAGR——

Interest Expense history

CAD · from the income statement

Latest · FY2025
9.91K CAD
Year-over-year change
-47.8%
4-year CAGR
-64.2%

Interest Expense vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -84.1% is the lowest of 5, against a peer median of -16.5%.
  • Interest expense amounts to 0.0% of revenue for HYFT, versus a peer median of 7.2%.
HYFT Competitors
Interest Expense for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FBIOFortress Biotech, Inc.LTM Mar 2026$9.57M USD-28.8%-13.9%14.5%
CLNNClene Inc.LTM Mar 2026$2.87M USD-16.4%-6.6%2138.1%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$1.53M USD-10.6%+88.8%—
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$55K USD-16.7%+127.9%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$1.94K CAD-84.1%-51.1%0.0%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$0 USD——0.0%
BYSIBeyondSpring Inc.LTM Mar 2026$0 USD———
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD———
ATYRaTyr Pharma, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding HYFT) —-16.5%+41.1%7.2%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.